Nimodipine in the current era of subarachnoid hemorrhage management: standard of care or primed for a definitive randomized trial?

Affiliations

¹ Department of Medicine, University Health Network, Toronto, Ontario, Canada; Interdepartmental Division of Critical Care and Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: eyal.golan@utoronto.ca.

Comment

Eyal Golan et al. J Crit Care. 2013 Dec.

. 2013 Dec;28(6):1102.

doi: 10.1016/j.jcrc.2013.08.001. Epub 2013 Sep 12.

¹ Department of Medicine, University Health Network, Toronto, Ontario, Canada; Interdepartmental Division of Critical Care and Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: eyal.golan@utoronto.ca.

No abstract available

Comment on

Prophylactic magnesium for improving neurologic outcome after aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis.
Golan E, Vasquez DN, Ferguson ND, Adhikari NK, Scales DC. Golan E, et al. J Crit Care. 2013 Apr;28(2):173-81. doi: 10.1016/j.jcrc.2012.07.001. Epub 2012 Nov 26. J Crit Care. 2013. PMID: 23192249
Combination therapy for subarachnoid hemorrhage--is nimodipine the wrong partner?
Westermaier T, Stetter C, Ernestus RI. Westermaier T, et al. J Crit Care. 2013 Dec;28(6):1101. doi: 10.1016/j.jcrc.2013.05.014. Epub 2013 Jul 16. J Crit Care. 2013. PMID: 23867720 No abstract available.